Mutagenesis of thrombin selectively modulates inhibition by serpins heparin cofactor II and antithrombin III. Interaction with the anion-binding exosite determines heparin cofactor II specificity.
Open Access
- 1 February 1993
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 268 (5) , 3639-3645
- https://doi.org/10.1016/s0021-9258(18)53741-8
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogsBiochemistry, 1990
- Serpin-resistant mutants of human tissue-type plasminogen activatorNature, 1989
- Antithrombin action of phosvitin and other phosphate‐containing polyanions is mediated by heparin cofactor IIFEBS Letters, 1988
- Anion-binding exosite of human .alpha.-thrombin and fibrin(ogen) recognitionBiochemistry, 1988
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- Kinetics of the inhibition of thrombin by hirudinBiochemistry, 1986
- Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell lineBiochemical and Biophysical Research Communications, 1985
- Ultrasensitive Stain for Proteins in Polyacrylamide Gels Shows Regional Variation in Cerebrospinal Fluid ProteinsScience, 1981
- The measurement of thrombin in clotting blood by radioimmunoassay.Journal of Clinical Investigation, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970